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Negative symptoms are a debilitating feature of schizophrenia which are often
resistant to pharmacological intervention. The mechanisms underlying them remain
poorly understood, and diagnostic methods rely on phenotyping through validated
questionnaires. Deeper endo-phenotyping is likely to be necessary in order to improve
current understanding. In the last decade, valuable behavioural insights have been
gained through the use of effort-based decision making (EBDM) tasks. These have
highlighted impairments in reward-related processing in schizophrenia, particularly
associated with negative symptom severity. Neuroimaging investigations have related
these changes to dysfunction within specific brain networks including the ventral
striatum (VS) and frontal brain regions. Here, we review the behavioural and neural
evidence associated with negative symptoms, shedding light on potential underlying
mechanisms and future therapeutic possibilities. Findings in the literature suggest that
schizophrenia is characterised by impaired reward based learning and action selection,
despite preserved hedonic responses. Associations between amotivation and reward-
processing deficits have not always been clear, and may be mediated by factors
including cognitive dysfunction or dysfunctional or self-defeatist beliefs. Successful
endo-phenotyping of negative symptoms as a function of objective behavioural and
neural measurements is crucial in advancing our understanding of this complex
syndrome. Additionally, transdiagnostic research–leveraging findings from other brain
disorders, including neurological ones–can shed valuable light on the possible common
origins of motivation disorders across diseases and has important implications for future
treatment development.
Keywords: effort-based decision making, motivated action selection, apathy, schizophrenia, negative symptom,
reward based learning
Abbreviations: NIMH, National Institute of Mental Health; EXP, diminished expression factor within the negative
syndrome; MAP, motivation and pleasure factor within the negative syndrome; PANSS, positive and negative syndrome
scale; SANS, scale for the assessment of negative symptoms; EBDM, effort based decision making; EEfRT, effort expenditure
for rewards task; BNSS, brief negative symptom questionnaire; AUC, area under the curve; FR, frequently rewarded; FLA,
frequently loss avoidant; OFC/vmPFC, orbitofrontal cortex/ventromedial pre-frontal cortex; ACC, anterior cingulate cortex;
VS, ventral striatum; VTA, ventral tegmental area; MRI, magnetic resonance imaging; BOLD, blood level oxygen dependent.
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INTRODUCTION
Negative symptoms are a core feature of schizophrenia, observed
in up to 90% of patients at first-episode psychosis (Kraepelin,
1921; Bleuler, 1950; Mäkinen et al., 2008; An der Heiden et al.,
2016). They include a constellation of symptoms unified by
the loss of “vital properties” such as speech, motivation and
self-expression (Berrios, 1985). Despite being less prominent in
presentation than the positive/psychotic features of schizophrenia
(e.g., hallucinations and delusions), negative symptoms are
independently associated with poor functional outcomes (Milev
et al., 2005; Rabinowitz et al., 2012, 2013; Fervaha et al., 2014)
and subjective well-being (Strauss et al., 2012), and can predict
future psychotic episodes (Piskulic et al., 2012). To date, there are
no licensed treatments specifically targeting negative symptoms,
in part likely due to a lack of understanding of their underlying
mechanisms. A better characterisation of such mechanisms might
therefore play a key role in treating their debilitating effects across
psychiatric conditions.
Recent development of behavioural paradigms to investigate
negative symptoms has significantly improved our understanding
of their phenotype (Gold et al., 2015; Culbreth et al., 2018).
Importantly, these behavioural measures have been related
directly to specific neural regions and networks in the
brain (Chase et al., 2018; Culbreth et al., 2018). Here we
discuss the history and current mechanistic understanding of
motivational aspects of the negative syndrome considering
these developments, whilst highlighting current gaps and future
therapeutic possibilities.
Negative Symptoms: The State of Play
Our conceptual understanding has progressed considerably since
the formalisation of a “negative syndrome” as early as 1974
(Strauss et al., 1974). Current classification of the negative
syndrome includes five symptom domains as agreed upon by the
National Institute of Mental Health (NIMH) consensus statement
(Kirkpatrick et al., 2006). These are: alogia, anhedonia, avolition,
asociality, and blunted affect (see Table 1 for definitions).
Questionnaire measures, which can help to support clinical
diagnosis, have been adapted to reflect the evolving definition of
the negative syndrome (Kirkpatrick et al., 2011).
TABLE 1 | Definitions of negative syndrome domains as defined
by NIMH consensus.
NIMH domain Definitions based on Kirkpatrick et al. (2011)
Anhedonia Reduced intensity and frequency of current or future
pleasurable activities.
Avolition A reduction in the initiation of and persistence in activity in
relation to internally guided behaviour and experiences.
Asociality Reduced social activity accompanied by a decreased
interest in forming close relationships with others.
Alogia A reduction in speech quantity, and spontaneous
elaboration in conversation.
Blunted affect A decrease in outward expression of emotion including
facial, vocal and expressive gestures.
Factor analyses of these questionnaire data have shed further
light on possible underlying structures of the negative syndrome.
For example, the results of some studies suggest that negative
symptom domains aggregate into a two-factor structure where
alogia and blunted affect form a “Diminished Expression” (EXP)
factor, while the remaining domains form a “Motivation and
Pleasure” (MAP) factor, which can be referred to as “apathy”
(Figure 1; Kimhy et al., 2006; Nakaya and Ohmori, 2008; Foussias
and Remington, 2010; Horan et al., 2011; Kirkpatrick et al., 2011;
Kring et al., 2013). This dichotomised view of negative symptoms
is reflected in the most recent version of the DSM-5 (Tandon
et al., 2013). However, other findings suggest a more complex
construct, providing some evidence against a simplistic two factor
model of negative symptoms (Strauss et al., 2018, 2019a,b).
Some challenges with frameworks based on questionnaire
analyses may be partly due to the use of different instruments
to assess negative symptoms (Garcia-Portilla et al., 2015; Kumari
et al., 2017). Previous studies have relied on questionnaires
containing symptoms that are no longer considered part of the
consensus statement definition of the negative syndrome (Peralta
and Cuesta, 1995; Sayers et al., 1996; Kumari et al., 2017).
For example, the widely used PANSS questionnaire (Positive
And Negative Syndrome Scale) includes “abstract thinking” as a
negative symptom, whereas the SANS (Scale for the Assessment
of Negative Symptoms) questionnaire includes an “inattention”
domain (Andreasen et al., 1991; Mortimer, 2007). Both these
components may reflect general cognitive dysfunction, currently
considered to arise separate from negative symptom mechanisms
in schizophrenia (Kirkpatrick et al., 2006).
It is evident that the complex negative syndrome remains
to be fully understood. While questionnaire analyses may
advance our understanding at the structural level, they lack
the ability to provide deeper mechanistic insight at behavioural
and anatomical levels. One potential way to address the current
knowledge gap is by application of an endo-phenotyping
approach to advance a neurocognitive framework of this
syndrome. A key area where this is being applied is in
disorders of motivation.
Effort-Based Decision Making
Framework for Motivation Deficits
Motivation deficits appear to be central to the negative syndrome
(Strauss et al., 2019c, 2021). An emerging framework that has
been used to conceptualize the motivational aspects of negative
symptoms is that of effort-based decision making for rewards
(EBDM). Paradigms that assess EBDM, some translated from
animal studies, have the potential to provide important insights
into the phenotypes of neuropsychiatric disease by probing
different phases of behaviour (Husain and Roiser, 2018). These
include the instrumental, consummatory and learning phases of
motivated behaviour outlined in Figure 2 and explained below.
When deciding whether to pursue a course action,
an individual may weigh up its potential benefits (e.g.,
reward/avoiding punishment) against its costs (e.g., effort/risk)
vs. other possible actions–a process referred to as “option
selection” (Husain and Roiser, 2018). Alternatively, having
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FIGURE 1 | Negative symptoms and conceptual groupings. Negative symptoms are often conceptually grouped into a motivation and pleasure (MAP) and blunted
expression (EXP) components. The former includes anhedonia, avolition, and asociality, whereas the latter includes alogia and emotional responsiveness.
Collectively, the motivation-pleasure symptoms are also sometimes referred to using the umbrella term “apathy.”
FIGURE 2 | Phases of effort-based decision making for rewards. Effort based decisions making can occur across three conceptual phases. Option selection
includes the processes of weighing up components of decisions and behaviourally manifests as wanting. Consummatory phase refers to the hedonic response and
represents the experience of liking. Learning reflects the process of updating beliefs based on a representation of the environment that is structured (i.e., model
based) or otherwise (model free). Framework adapted from Berridge and Robinson (2003) and Husain and Roiser (2018).
invested some effort towards a specific goal, one may re-evaluate
the merit of sustaining further effort in its pursuit. Paradigms
examining these processes in patient groups can manipulate the
benefits and costs of actions systematically to highlight potential
deficits in effort-based decisions (Treadway et al., 2009; Le Heron
et al., 2018b). Some frameworks conceptualise these processes
as encompassing the “wanting” or instrumental components of
motivated behaviour to seek a particular outcome (Salamone and
Correa, 2012; Thomsen et al., 2015).
Whereas the decision making process represents the
“wanting” aspect of behaviour, consummatory behaviour
encompasses the hedonic response or the “liking” component
when interacting with the goal of behaviour (Salamone and
Correa, 2012; Thomsen et al., 2015). When an individual engages
in pleasurable activity (e.g., watching a comedy), they may
respond explicitly (e.g., rating their experience), or implicitly
(e.g., smiling) (Berenbaum and Oltmanns, 1992; Berridge and
Robinson, 2003). One or more of these responses may be altered
in patients with negative symptoms (Berenbaum and Oltmanns,
1992; Cohen and Minor, 2010).
Having engaged in a behaviour with an unexpected
positive/negative outcome, expectations of reward may be
updated in relation to behaviour. In laboratory settings, this
can be achieved by varying the frequency of rewarding different
actions. For example, one response may be rewarded 90% of time
and another only 60% of the time (Hernaus et al., 2018; Culbreth
et al., 2021). Over the course of an experiment, participants
learn to favour one action based on the frequency of reward
(or reinforcement schedule). Deficits in the learning process
may impair individuals from representing the value of reward
appropriately to guide future motivated behaviour to influence
future decisions.
The last decade has seen a significant rise in EBDM studies in
schizophrenia spanning several of these components of decision
making (Gold et al., 2013; Barch et al., 2014; Albrecht et al.,
2019; Chang et al., 2019, 2020; Cooper et al., 2019; Culbreth
et al., 2021). The investigations that have been performed aimed
to probe cognitive mechanisms underlying behavioural deficits,
including negative symptoms. Phenotypes can be captured using
tasks that probe different aspects of EBDM based on behavioural
performance, but they can also be derived from computational
modelling of behaviour on such tasks and subsequently correlated
with symptoms of interest. This approach has been used
to investigate apathy and anhedonia across several disorders
Frontiers in Behavioral Neuroscience | www.frontiersin.org 3 September 2021 | Volume 15 | Article 709753
fnbeh-15-709753 September 4, 2021 Time: 17:35 # 4
Saleh et al. Apathetic Behaviour in Schizophrenia
(Muhammed et al., 2016; Husain and Roiser, 2018; Le Heron
et al., 2018a,b; Pessiglione et al., 2018; Berwian et al., 2020).
As both these symptoms occur in the negative syndrome, it is
possible that analysis of performance on EBDM tasks can also add
value to the mechanistic understanding of negative symptoms
in schizophrenia.
Instrumental Behaviour: Option Selection
One of the earliest and most commonly used EBDM paradigms
is that developed by Treadway et al. (2009, 2015) known as the
“Effort Expenditure for Rewards Task” (EEfRT). This paradigm
and its variations have been widely used to probe option selection
in patients and healthy controls (Fervaha et al., 2013; Barch
et al., 2014; Hartmann et al., 2015; Treadway et al., 2015; Chang
et al., 2019) and have demonstrated good test-retest reliability
(Reddy et al., 2015) and external validity (Horan et al., 2015). In
this task participants exert physical effort either by selecting to
press on a key using the dominant index finger (low-effort) or
the non-dominant little finger (high-effort). While the low effort
condition is paired with a single fixed low reward (e.g., $1), the
high effort condition can be paired with one of four possible
higher reward magnitudes (e.g., $1.3–$4.3). Additionally, the
outcome probability is varied across all conditions to incorporate
an element of uncertainty (25, 50, or 88%). On a trial by trial basis,
participants are offered either a low reward–low effort condition
or a high reward–high effort condition with outcome probability
varied (Figure 3A).
The most consistent finding reported using this task is
that schizophrenia patients paradoxically accept less offers than
healthy controls when reward levels and probabilities are the
highest (Fervaha et al., 2013; Gold et al., 2013; Barch et al.,
2014; Hartmann et al., 2015; Horan et al., 2015; Reddy et al.,
2015; Treadway et al., 2015; McCarthy et al., 2016; Moran et al.,
2017). Further, some studies demonstrate that this effect is most
pronounced in patients with higher negative symptom severity
(Gold et al., 2013; Hartmann et al., 2015; Cooper et al., 2019),
although this finding is not consistent (Fervaha et al., 2013;
Barch et al., 2014; Horan et al., 2015; Moran et al., 2017).
These inconsistencies might arise due to a variety of reasons
which include use of different analysis approaches (Fervaha
et al., 2013; Horan et al., 2015), questionnaire types (Fervaha
et al., 2013; Hartmann et al., 2015; Moran et al., 2017) or task
variations (Horan et al., 2015). In those investigations where
there were significant associations between performance and
negative symptoms, correlations tended to bias toward the MAP
components (Figure 1) of the negative syndrome (i.e., avolition,
asociality, and anhedonia) and not the expressive component
(i.e., alogia and blunted affect) (Fervaha et al., 2013; Barch et al.,
2014; Hartmann et al., 2015; Cooper et al., 2019).
One critique of the EEfRT task and some of its variations is
that it does not vary reward and effort equally. In the version of
the task that has been most frequently deployed, there are five
reward manipulations and only two effort conditions (Figure 3A;
Barch et al., 2014). This makes it difficult to interpret how
reward and effort processing individually contribute to altered
decision making in schizophrenia. Specifically, it is not clear if the
deficits in evaluating reward value across different magnitudes
also extend to effort. Future work might benefit from utilising
task structures which parametrically and symmetrically co-vary
reward and effort. Additionally, it would be important to define
negative symptom severity using more modern instruments like
the brief negative symptom questionnaire (BNSS) (Kirkpatrick
et al., 2011). Consistent use of these measures across studies
might improve interpretability of associations between negative
symptom severity and behavioural parameters.
While the EEfRT task manipulated physical effort, other
studies have investigated the effects of cognitive effort on decision
making in schizophrenia (Gold et al., 2014; Reddy et al., 2015,
2018; Culbreth et al., 2016, 2020; Chang et al., 2020). These
include paradigms where participants chose to perform either a
cognitively simple operation for a fixed-low reward, or a more
demanding one for variable high rewards (Reddy et al., 2015,
2018). In one example, the two choices were represented by two
decks of cards (Figure 3B; Reddy et al., 2018). In the “difficult”
deck asked participants were asked to alternate between one
of two mental operations (e.g., is the displayed number odd?
Or is this number greater than five?), whereas the “easy” deck
repeated a single operation across all trials (e.g., is this number
greater than five?) (Reddy et al., 2018). Schizophrenia patients
accepted far fewer offers in the high effort-high reward condition
when compared to controls. However, there was no direct
relationship between offers accepted and negative symptoms,
although including mediating factors (e.g., dysfunctional beliefs
such as: “Why bother, I’ll just fail again”) in the analyses yielded
an indirect significant association (Reddy et al., 2018).
Another paradigm that has been used to examine cognitive
effort is the “N-back” working memory task, where participants
are asked if a displayed letter in a rapid, serial sequence is
identical to the one presented “N” steps previously (Figure 3C;
Westbrook et al., 2013). For example, the “easy” 1-back condition
involves comparing each letter to the preceding one in the
sequence and reporting if it is the same or different. On the
other hand, the more challenging 4-back condition requires
a comparison of each letter with the one shown four steps
previously. Typically, participants were given a choice between a
1-back trial at low reward ($1) or a 2–4 back trial for high reward
($2) (Culbreth et al., 2016, 2020; Chang et al., 2020). Critically,
the value of the low-reward condition was adjusted based on
the previous trial’s response. For example, if the low-reward
trial was rejected, in subsequent trials its value was increased
stepwise up to an “indifference point” where participants were
equally likely to choose either offer. The indifference point is a
measure of how effort “discounts” reward across trial types, and
was used to compute a per condition subjective value as well as
an overall summary measure of value known as the area under
the curve (AUC).
Schizophrenia patients discounted rewards more steeply than
controls as a function of cognitive effort on the N-back task
(Culbreth et al., 2016, 2020; Chang et al., 2020). This effect, as
measured by the subjective value (Chang et al., 2020; Culbreth
et al., 2020) or AUC (Culbreth et al., 2016), was specifically
associated with negative symptom severity (Culbreth et al.,
2016, 2020; Chang et al., 2020). However, the nature of these
associations is not very clear. For example, in a recent study
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FIGURE 3 | Effort based decision making tasks in schizophrenia. Schematic representation of four paradigms (A–D). The EEfRT task (A) varies physical effort in
return for monetary reward. Participants choose between a high effort-high reward condition and low effort-low reward condition. Additionally, probability of winning
varies across trial types. Adapted from Treadway et al. (2009). The deck choice effort task and the N-back task (B,C) both use cognitive instead of physical effort in a
similar task structure to the EEfRT task, although probability is not varied. (B) In the deck choice task, high effort involves serially alternating between two mental
activities, whereas only one mental activity is performed in the low effort option. (C) In the N-back task participants are serially presented with a list of letters and
asked if the same letter was presented N steps back. They choose between a 1-back trial for low reward or a higher N-back (e.g., 4-back) for higher reward.
(D) Learning paradigms involve choosing between two partially reinforced images to either gain reward, or avoid loss (see subsection “Reinforcement learning of
reward value”). In a learning phase, only two images are presented per trial and one type of outcome is varied per block (reward gain vs. loss avoidance).
A subsequent transfer phase uses novel combinations of visual stimuli to investigate learning behaviour across trial types.
by Chang et al. (2020) the relationship between behaviour and
negative symptoms varied depending on the outcome measure
of interest. After taking the sum of anhedonia, asociality,
and avolition scores on the BNSS questionnaire, schizophrenia
patients were split down the median into amotivation+ and
amotivation− sub-groups. When comparing the proportion
of high reward-high effort responses, both amotivation+ and
amotivation− sub-groups accepted fewer offers compared to
healthy volunteers. On the other hand, a comparison of subjective
value between groups revealed a significant decrease in this
parameter the amotivation+ sub-group compared to controls,
but there was no difference between the amotivation+ and
amotivation− patients. Finally, there was no association between
the AUC measure and negative symptoms in this particular study,
which contrasts with findings by other groups using very similar
paradigms (Culbreth et al., 2016).
Taken together, these findings suggest that schizophrenia
patients are impaired in the “option selection” process of
motivated behaviour (Figures 3A–C). Specifically, they forego
high reward opportunities when they are coupled with high
effort costs. This effect is present regardless of whether the
cost is physical (EEfRT) or cognitive (N-back). Investigations
utilising the EEfRT task suggest these deficits might arise due
to impairments in constructing reward value (Gold et al., 2013;
Barch et al., 2014; Reddy et al., 2015; Treadway et al., 2015) while
N-back experiments support an additional role for cognitive
effort avoidance (Culbreth et al., 2016, 2020; Chang et al., 2020).
Both behavioural deficits are associated with negative symptom
severity, however, these relationships may be more nuanced than
initially proposed. If the value of reward is discounted more easily
in patients with negative symptoms, is this because they cannot
experience pleasure?
Interaction With Behavioural Goals:
“Liking” but Not “Wanting”
It might be argued that schizophrenia patients are less motivated
by reward because they experience less pleasure. However, the
evidence points to the contrary (Berenbaum and Oltmanns, 1992;
Horan et al., 2006; Burbridge and Barch, 2007; Herbener et al.,
2007; Barch et al., 2016). In fact, schizophrenia patients frequently
report similar levels of pleasure to healthy volunteers in response
to positive experiences like consuming a sugary drink or watching
a funny video clip (Berenbaum and Oltmanns, 1992; Horan et al.,
2006). This phenomenon of preserved hedonic responses has
been replicated throughout the literature, and is summarised in
a meta-analysis by Cohen and Minor (2010). So why do patients
continue to display poor motivation for rewards while enjoying
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pleasurable activities? One view is that it is not the hedonic
response per se that is affected in schizophrenia, but the ability
to anticipate future pleasure from self-guided action. In other
words patients may not “want” to engage in pleasurable activities
despite reporting that they “like” those activities (Gard et al., 2007;
Herbener et al., 2007; Edwards et al., 2015; Moran and Kring,
2018).
Early research supporting this proposal involved serial
collection of self-ratings from schizophrenia patients and healthy
individuals over the course of a week (Gard et al., 2007).
Participants reported how much pleasure they derived from
current and future activities (e.g., eating dinner). Despite showing
similar pleasure ratings while engaged in current activities,
they reported significantly less anticipatory pleasure for future
actions. Forthcoming, but not current, activity ratings were
associated with familial and social functional outcome measures.
Other paradigms relied on the presentation of serial images
with positive (cupcake), neutral (chair), or negative (snake)
associations (Herbener et al., 2007; Edwards et al., 2015; Moran
and Kring, 2018).
Subtle methodological variations permitted separate
measurements of both consummatory (i.e., current) and
anticipatory (i.e., future) pleasure assessments. For example,
in one setting a preceding symbol denoted the image category
(e.g., +sign before positive image) and ratings were collected
at this stage as well as during image presentation (Edwards
et al., 2015). In another, images rated as highly pleasant or
unpleasant at presentation were then associated with a neutral
cue and subsequent ratings were made in response to the neutral
cue presentation (Moran and Kring, 2018). In both studies,
patients reported similar levels of consummatory but reduced
anticipatory pleasure (Edwards et al., 2015; Moran and Kring,
2018). Further, they not only undervalued the pleasantness of
future reward (Moran and Kring, 2018), but rated unpleasant
images less severely in comparison to healthy participants
(Edwards et al., 2015; Moran and Kring, 2018). This dampening
of anticipatory pleasure was correlated with negative symptom
severity (Moran and Kring, 2018).
Taken together, this evidence suggests that schizophrenia
patients are less able to represent reward value when considering
future actions–the “wanting” or instrumental aspects of
motivated behaviour. Moreover, this is both associated
with functional outcomes, as well as negative symptom
severity. So why does a patient with negative symptoms
lose the ability to represent future reward appropriately? Do
they suffer from a general inability to learn about reward?
Or might there be specific learning deficits that give rise
to this?
Reinforcement Learning of Reward Value
Several investigations have employed reinforcement learning
paradigms to further explore the hypothesis that the
representation of reward value is impaired in schizophrenia
(Figure 3D; Gold et al., 2008, 2012; Strauss et al., 2011;
Yilmaz et al., 2012; Moran et al., 2017; Hernaus et al., 2018;
Culbreth et al., 2020). In one experiment conducted by Gold
et al. (2012), participants were presented with image pairs of
different landscapes and asked to choose the “correct” option.
In half the trials, choosing the correct answer resulted in
monetary gain (vs. no gain if incorrect), and in the other half
it prevented monetary loss (vs. a loss if incorrect). Correct
responses were reinforced at varying probabilities for each pair
(i.e., they were rewarded on 90 or 80% of trials). After learning
all possible associations, participants were asked to choose
the best option between novel combinations of the original
images in a “transfer” phase (Gold et al., 2012). Investigators
were particularly interested in comparing the most frequently
rewarded option (FR) with the most frequently loss avoidant one
(FLA) (Figure 3D).
In the learning phase, schizophrenia patients with high
negative symptom severity demonstrated impaired learning in
the conditions rewarded with high probability (90%) when
compared to controls. However, loss-avoidance learning was
intact, suggesting that reward-based learning was specifically
affected. When faced with a direct comparison between FR
and FLA choices, healthy participants selected the FR option
significantly more often than patients with high negative
symptoms. In other words, healthy participants and patients
without negative symptoms incorporated the expected value of
responses in their decisions more frequently than patients with
high negative symptoms.
In computational terms, updating decisions based on future
expected value was considered to be encoded in a “model-
based” process termed Q-learning (Hernaus et al., 2018). One
hypothesis is that patients with high negative symptom severity
have lower Q-learning rates. Instead, they select options more
frequently based on the accumulation of unexpected positive
outcomes, or reward prediction errors, regardless of the future
expected value. This process is encoded in a “model-free” process
known as the actor-critic model (Hernaus et al., 2018). In
this scenario, avoiding loss and gaining reward both classify as
positive outcomes when compared to their paired alternatives
(no gain and loss, respectively). As a result, when directly
compared, they are selected indiscriminately despite only one of
these outcomes (gaining reward) increasing expected value. In
summary, this study proposed that reward processing deficits in
schizophrenia are characterised by a reduction in Q-learning and
an increase in actor-critic learning.
Subsequently, the same group proposed that Q-learning
deficits should be most noticeable when comparing options
with the largest (i.e., easiest) discriminations in expected value
(Hernaus et al., 2018). To address this possibility, Hernaus
et al. (2018) used a similar paradigm to compare responses
to image pairs with three different probabilities (90:10, 75:25,
and 60:40). As expected, schizophrenia patients accepted less
offers than controls at the highest (90:10 and 75:25) probabilities,
but not lower probabilities (60:40). Using a logistic regression,
the authors were able to confirm that the group differences
could be detected as a function of the expected value difference
(Hernaus et al., 2018).
Next, they attempted to capture these findings using
a computational model that incorporated model-based (Q-
learning) and model free (actor-critic) learning. The hypothesis
was that the expected value difference could be modelled using
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a mixing parameter (m) representing the extent of model-
based/model-free learning employed by each subject. Further,
this parameter should relate to both group differences and
possibly negative symptom severity (Hernaus et al., 2018). At the
group level, the investigators were able to demonstrate that the
m parameter captured the difference in expected value and was
lower in schizophrenia patients compared to healthy volunteers.
However, there was no association between this parameter and
negative symptoms severity. This finding that reward based
learning is most impaired at the highest probabilities has been
reported across different learning paradigms (Yilmaz et al., 2012;
Chang et al., 2016; Moran et al., 2017), but not accounted for with
a single model previously.
In view of these results, one surprising finding across studies
is that schizophrenia patients demonstrate intact general learning
ability (Gold et al., 2012; Moran et al., 2017; Hernaus et al.,
2018; Culbreth et al., 2020). That is, they can learn about rewards
in general. For example, schizophrenia patients display similar
overall accuracy in choices to controls in the transfer phase
(Moran et al., 2017; Hernaus et al., 2018; Culbreth et al., 2020) and
accurately favour frequently rewarding options over frequent loss
ones (Gold et al., 2012). When faced with two relatively positive
choices, however, they are less able to determine which response
leads the best outcomes.
To sum up, schizophrenia patients appear to suffer
impairments in reward-based learning due to a specific
deficit in representing expected value. This impairment is
specific to reward learning and not loss avoidance (Gold et al.,
2012). Nevertheless, there still seems to be a lack of clarity
about how exactly these behavioural deficits specifically relate
to negative symptoms severity. One possible explanation is
that the behavioural deficits related to negative symptoms
are mediated by factors including cognitive impairment,
dopaminergic treatment, or dysfunctional attitudes. We explore
these possibilities briefly in the following section.
Cognitive Dysfunction and Reward
Processing
Cognitive dysfunction is a well-documented core phenomenon
in schizophrenia (Heinrichs and Zakzanis, 1998; Kahn and
Keefe, 2013; Schaefer et al., 2013), but the association with
negative symptom questionnaires is complex (Harvey et al.,
2006). While questionnaire analyses reveal correlations between
negative symptoms and cognitive impairment (O’Leary et al.,
2000; Good et al., 2004), these associations are often modest
and weakened when adjusting for confounding factors such as
functional outcomes (Heydebrand et al., 2004; Bowie et al., 2006;
Couture et al., 2011). In the case of EBDM, impaired cognitive
function has been shown to be associated with altered decision
making for rewards (Heerey et al., 2007, 2008). Notably, a recent
re-analysis of several studies using the EEfRT task demonstrated
that schizophrenia patients with difficulties in constructing value
representations were characterised by greater impairments across
measures of cognitive function (Cooper et al., 2019). Hence,
reward sensitivity is not only altered by negative symptoms but
also by cognitive impairment.
These findings suggest negative symptoms and cognitive
dysfunction are, at the very least, highly interdependent and
might operate in tandem to regulate motivated behaviour
(Robison et al., 2020). A better characterisation of this interaction
at the behavioural level would be imperative in uncovering the
relationship between negative symptoms, cognitive impairment
and EBDM. One emerging hypothesis suggests that altered
behaviour associated with negative symptoms and cognitive
impairment is mediated by dysfunctional attitudes and/or
defeatist beliefs (Grant and Beck, 2009; Horan et al., 2010;
Quinlan et al., 2014). So far, two investigations have additionally
associated these beliefs to performance on EBDM tasks
(Granholm et al., 2016; Reddy et al., 2018).
In one study, patients with high scores on self-defeatist
beliefs demonstrated reduced pupillary dilation while recalling
increasingly complex numeric sequences (Granholm et al., 2016).
Additionally, negative symptom severity positively correlated
with self-defeatist beliefs. More recently, Reddy et al. (2018)
showed that schizophrenia patients accepted less offers at high
reward-high cognitive effort compared to healthy volunteers.
While there was no direct association between responses and
negative symptoms, when the interaction term between negative
symptoms and self-defeatist beliefs was included as a covariate,
there was a significant positive association between the number
of offers accepted and this interaction term (Reddy et al., 2018).
Additionally, cognitive impairment was the strongest predictor of
task performance across analyses, but the authors did not explore
the interactions between cognitive function, negative symptoms,
and dysfunctional beliefs. These preliminary findings suggest that
mediating factors like cognition and/or dysfunctional beliefs may
play a role in linking EBDM deficits and negative symptoms in
schizophrenia. Hypothesis driven mediation analyses in future
behavioural work may further clarify these complex associations.
Dopamine and Effort-Based Decision
Making
Regulation of the neurotransmitter dopamine is heavily
implicated both in EBDM and the pathophysiological changes in
schizophrenia (Davis et al., 1991; Salamone et al., 2007; Maia and
Frank, 2017). Additionally, most antipsychotic medications used
in schizophrenia target dopaminergic D2 receptors (Miyamoto
et al., 2005). Several studies have found no associations between
antipsychotic dose equivalents and negative symptoms (Gold
et al., 2013; Chang et al., 2020). Crucially, they also failed to find
a relationship between EBDM deficits and negative symptom
severity (Fervaha et al., 2013; Gold et al., 2013; Barch et al., 2014;
Chang et al., 2020).
One interpretation of this lack of association is that
most investigations do not dissociate between antipsychotic
medication based on D2 receptor affinity (Gold et al., 2015).
Specifically, Gold et al. (2015) showed in a small sample that
patients on first generation antipsychotics were significantly less
likely to expend effort for rewards in comparison to patients on
second generation medications like clozapine. However, this was
based on a small sample size (16 cases on clozapine) and a more
sizeable replication of this work is necessary.
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A recent analysis of 196 patients demonstrated an inverse
association between negative symptom severity and medication
dose that was specific for atypical antipsychotic therapy, but
this study did not investigate effort-based decisions (Fujimaki
et al., 2018). There would be considerable potential value in a
conducting well-powered EBDM tasks in patients on different
antipsychotic medications. Demonstrating distinct behavioural
and questionnaire responses on first vs. second generation
anti-dopaminergic drugs might influence both current clinical
practice as well as future therapeutic development.
Neural Correlates of Reward Processing
in Schizophrenia
The results of neuroimaging studies in healthy people have
revealed that reward related processing occurs in distinct areas
of the brain (Figure 4; Pessiglione et al., 2018). Typically, these
are regions in the medial frontal cortex and basal ganglia:
the orbitofrontal cortex (OFC) sometimes referred to as the
ventromedial pre-frontal cortex (vmPFC), anterior cingulate
cortex (ACC), ventral striatum (VS) including the nucleus
accumbens, and the ventral tegmental area (VTA) of the
midbrain (Croxson et al., 2009; Bartra et al., 2013; Bonnelle
et al., 2016). Tracer studies in animals and tractography analyses
in humans have revealed that these areas are interconnected in
an extensive network (Haber and Knutson, 2010). Functional
neuroimaging studies demonstrate that both the OFC and
VS are activated in anticipation of rewards (Croxson et al.,
2009; Kroemer et al., 2014), while the ACC encodes subjective
value by integrating reward and effort signals (Croxson et al.,
2009; Bonnelle et al., 2016). Lesions studies offer additional
support for these findings. Specifically, OFC and VS lesions
are associated with altered sensitivity to rewards as measured
by pupillary responses (Manohar and Husain, 2016). Recently,
Manohar and Husain (2016) showed that patients with vmPFC
lesion completing a gambling task were less reliant on the
expected value of rejected options when compared to controls.
Additionally, lesions within the ACC are associated with severe
forms of apathy known as akinetic mutism (Barris and Schuman,
1953; Németh et al., 1988), whereas lesions in the basal ganglia,
and thalamus can also lead to significant decreases in motivation,
although this may improve with dopaminergic therapy (Adam
et al., 2013; Blundo and Gerace, 2015). Preclinical studies
lend further support to the role of these brain regions in
facilitating motivated behaviour, namely through dopaminergic
transmission (reviewed in Floresco et al., 2008; Salamone et al.,
2018). In food deprived rodents, dopamine depletion within
the nucleus accumbens leads to significant reductions in effort
exertion during feeding behaviour (Salamone, 1988; Salamone
et al., 1991; Koch et al., 2000). Together, this evidence implicates a
distinct neural network in the regulation of motivated behaviour,
possibly through dopaminergic transmission.
Might these brain regions be disrupted in schizophrenia, and
what is their association with negative symptom severity?
Early evidence from Functional MRI studies suggests
both schizophrenia and negative symptom severity are
associated with impairments within the fronto-striatal network
FIGURE 4 | Brain regions associated with reward and effort processing.
Based on a meta-analysis of functional MRI studies (Pessiglione et al., 2018).
Reward processing associated with activation in the ventromedial pre-frontal
cortex (vmPFC), ventral striatum (VS), and ventral tegmental area within the
midbrain. Effort processing clusters are principally found in the dorsal anterior
cingulate cortex (ACC) and anterior insula (AI). Adapted from Figure 5 in
Pessiglione et al. (2018).
(Walter et al., 2009; Dowd and Barch, 2012; Arrondo et al., 2015;
Subramaniam et al., 2015; Moran et al., 2019; Shukla et al., 2019;
Xu et al., 2019). Neural activation, inferred from blood oxygen
level dependent (BOLD) signals, was compared between patients
and healthy controls while performing various reinforcement
learning paradigms (Walter et al., 2009; Dowd and Barch, 2012;
Arrondo et al., 2015; Subramaniam et al., 2015). One example
involved responding with a key press to either a positive cue
(e.g., upwards arrow) or neutral cue (e.g., horizontal arrow).
Positive cues were followed by one of two monetary rewards (a
pound vs. a penny), whereas neutral cues preceded one of two
colours (yellow vs. brown circle). When anticipating rewards,
schizophrenia patients showed less activation in several brain
regions in comparison to healthy participants (Walter et al.,
2009; Dowd and Barch, 2012; Arrondo et al., 2015; Moran et al.,
2019). These included the VS (Walter et al., 2009; Arrondo et al.,
2015), ACC (Walter et al., 2009; Arrondo et al., 2015; Moran
et al., 2019), and OFC (Arrondo et al., 2015). Blood oxygen
level dependent signal strength in these regions was found to be
negatively associated with MAP symptoms in patients (Moran
et al., 2019), although this finding is not consistent (Dowd and
Barch, 2012; Arrondo et al., 2015). For example, two earlier
experiments demonstrated that reduced VS activation during
reward anticipation was only associated with anhedonia, and
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not other components of the negative syndrome (Dowd and
Barch, 2012; Arrondo et al., 2015). Functional connectivity has
also been assessed in schizophrenia (Shukla et al., 2019; Xu et al.,
2019). This involves voxel-wise correlation of BOLD signal time
series between spatially distributed brain areas (Shukla et al.,
2019; Xu et al., 2019). The assumption is that regions that show
high similarity in BOLD signal are likely to be functionally
connected (Woodward and Cascio, 2015). Compared to 139
healthy volunteers, 95 schizophrenia patients showed significant
reductions in functional connectivity within the striatum-OFC
and striatum-ACC (Shukla et al., 2019). Additionally, the extent
of the impairment within the striatum-OFC was dependent
on negative symptom severity. This finding was replicated in
a cohort study of 84 schizophrenia patients, where VTA-OFC
connectivity was negatively associated with social amotivation
(Xu et al., 2019). Together, this evidence suggests that negative
symptoms in schizophrenia patients are associated with reduced
functional activation during reward anticipation as well as altered
functional connectivity within the fronto-striatal network.
Clinical apathy in neurological conditions like Parkinson’s
disease (Baggio et al., 2015) and cerebrovascular small vessel
disease (Hollocks et al., 2015; Saleh et al., 2021) is also associated
with structural and functional deficits within the medial forebrain
regions and the basal ganglia, including the VS (Hollocks
et al., 2015; Le Heron et al., 2018a; Saleh et al., 2021). This
suggests that some negative symptoms, like apathy/motivation
may have similar underlying neural origins, across different
diseases (Husain and Roiser, 2018). Such a view has been recently
proposed by Strauss and Cohen (2017) in a transdiagnostic view
of negative symptoms.
SUMMARY AND CONCLUSION
Negative symptoms are an important feature of schizophrenia.
Several lines of evidence suggest that they have a deleterious
impact on functional outcomes, so finding treatments that could
ameliorate them are considered an important goal of current
research. Our understanding of the “negative syndrome” might
be advanced by using well-designed EBDM tasks that probe the
different phases of behaviour (Figure 2). To date, these paradigms
reveal consistent deficits in motivated decision making when
evaluating rewards against physical (EEfRT) or cognitive (N-
back) effort (Gold et al., 2013; Barch et al., 2014; Chang et al.,
2020; Culbreth et al., 2020). This may be due to one or a
combination of reduced reward sensitivity and increased effort
avoidance. Deeper exploration of schizophrenia patients’ hedonic
responses demonstrates that negative symptoms do not reduce
the experience of “liking” pleasure (Barch et al., 2016). Instead,
they anticipate less enjoyment from future activities, and might
therefore “want” to do less than healthy people.
Assessments using reinforcement learning paradigms suggest
that reward processing deficits arise in patients because they put
less emphasis on the expected value of decisions (Hernaus et al.,
2018). Instead, they are guided by the basic stimulus-response
relationships between action and outcome. Computational
models which attempt to frame behavioural deficits this way are
very appealing, but while they capture overall behaviour they
do not currently consistently relate it to negative symptoms
(Hernaus et al., 2018). Perhaps such models may overfit the
data, and subsequently affect associations with questionnaires.
Alternatively, it might be that conventional negative symptom
questionnaires do not provide the most robust link to the
behavioural observations of interest. One factor complicating
interpretation is that different studies are inconsistent in which
questionnaires they use.
Another is that the relationship between negative symptoms
and reward representation might be mediated by other factors.
There is increasing interest in how cognitive impairment, or
accompanying dysfunctional beliefs, might bridge the association
between negative symptoms and altered effort-based decisions
(Reddy et al., 2018; Cooper et al., 2019; Robison et al., 2020). This
area may prove valuable in explaining some of the inconsistencies
between studies when relating deficits in reward based learning
and option selection to negative symptoms. Similarly, there is a
gap in the current understanding of how treatment with different
dopamine receptor antagonists differentially impacts negative
symptoms and EBDM.
Negative symptoms are associated with specific changes
within a fronto-striatal network that is closely associated with
EBDM (Moran et al., 2019; Shukla et al., 2019; Xu et al., 2019).
This is particularly interesting as this network is also associated
with clinical apathy in neurological diseases (Hollocks et al.,
2015; Saleh et al., 2021). Exploring the neural and behavioural
differences between negative symptoms across diseases is an
exciting future area of research. An important factor in pursuing
transdiagnostic enquiries of negative symptoms is to account
for variations in terminology across clinical specialties. For
example, negative symptoms include avolition, anhedonia, and
asociality under a single rubric (MAP). On the other hand,
neurologists and mood disorder specialists often refer to clinical
apathy as an independent syndrome which may overlap with
anhedonia (Husain and Roiser, 2018). Further, clinical apathy
as defined in this manner contains several symptom dimensions
(e.g., behavioural, social, and emotional) which overlap with
MAP symptoms (Marin et al., 1991; Kirkpatrick et al., 2006;
Sockeel et al., 2006; Ang et al., 2017). Behaviourally, apathetic
patients with cerebrovascular (Le Heron et al., 2018a; Saleh
et al., 2021), and Parkinson’s disease (Le Heron et al., 2018b)
display reward processing deficits when performing an EBDM
task. Specifically, they accept less monetary offers at low
reward compared to their motivated counterparts (Le Heron
et al., 2018a,b; Saleh et al., 2021). This is a slightly different
behavioural pattern to that demonstrated in schizophrenia
patients with negative symptoms, where less offers are accepted
at the highest reward levels (Gold et al., 2013, 2015). These
subtle differences imply that while both syndromes alter reward
processing, their behavioural phenotypes are not identical.
Differences may be due to diverging pathological processes at the
neural level, specific co-morbidities (e.g., cognitive impairment),
or pharmacological interactions (e.g., with anti-dopaminergic
medication). Transdiagnostic investigations across motivation
disorders will ensure that these differences are better defined
and accounted for. Additionally, using questionnaires designed
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specifically for transdiagnostic purposes can be valuable when
comparing findings across patient groups.
One limitation of the conceptual framework discussed here
is that it does not address components and contributors of
negative symptoms outside of EBDM. Specifically, while we
explore negative symptoms at the individual level we do not
discuss the environmental contributions to negative symptom
severity, which can be significant (van Os et al., 2002; Oshima
et al., 2005; Van Os et al., 2010). A recent review poses a
theoretical framework of how this can be integrated within
individual factors (Strauss, 2021). While our current concepts of
negative symptoms remains relatively modest, future approaches
might explore the interactions between environmental factors
and EBDM at the individual level. A related consideration
is whether the expressive symptoms (alogia/blunted affect) of
schizophrenia can be similarly quantified using behavioural tasks.
While effort-based decisions seem to be more influenced by
motivational deficits (anhedonia/avolition/asociality), there is
an increasing body of literature using different approaches to
quantify both emotional (Trémeau, 2006; Carter et al., 2009;
Prochwicz and Rózycka, 2012) and verbal (Cohen et al., 2014)
deficits in schizophrenia. These include facial recognition tasks
(Carter et al., 2009), as well as speech analysis techniques
(Cohen et al., 2020), both of which may offer valuable
contributions to our future understanding of negative symptoms
(Jeganathan and Breakspear, 2021).
In summary, motivational deficits are an important facet
of schizophrenia and its underlying mechanisms has the
potential to be advanced through well-designed behavioural
and neuroimaging research. A better understanding of how
amotivation alters reward-processing and which brain regions
are implicated can provide the foundations for future treatment
strategies. The transdiagnostic nature of these deficits poses
the distinct possibility that future treatments for motivation
deficits in schizophrenia might benefit patients with other
brain disorders.
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